Pular para o conteúdo principal
Ranking Invest

FATE - Fate Therapeutics, Inc.

Segmento: HealthcareFate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat multiple myeloma; FT819 to treat hematologic malignancies and solid tumors; FT536 to treat solid tumors; and FT500 for the treatment of advanced solid tumors. The company has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of two off-the-shelf iPSC-derived CAR T-cell product candidates; strategic research collaboration and license agreement with Juno Therapeutics, Inc. to screen for and identify small molecule modulators that enhance the therapeutic properties of genetically-engineered T-cell immunotherapies; and a collaboration and option agreement with Janssen Biotech, Inc. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Análise Ranking Invest

Valor de Mercado
$ 246.83 Mi
IVR
-1.81Índice proprietário de comparação relativa: -1,81.
IVR2
-2.44Leitura proprietária complementar: -244%.
MLL
-2.44Leitura proprietária complementar: -244%.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia proprietária baseada em dados financeiros públicos; fórmulas e valores intermediários são confidenciais.

Dados da Empresa

Patrimônio Líquido

$ 153.44 Mi

Dívida Líquida

-$ 32.43 Mi

L4T

-$ 126.00 Mi

MM4T

-2017.15%

Indicadores Básicos

ROE

-82.12%

Índices de Previsibilidade

Receita Líquida

G89.10

Lucro

B0.15

Margem

C0.51

Índices de Tendência

Receita Líquida

E-6.77

Lucro

B5.53

Margem

E-1.97

Índices de Endividamento

DIV/PAT

-0.21

DIV/L4T

0.26

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.